ASTRAZEN

AstraZeneca Pharma India vs Peers

₹5,923.00-0.96%
Market cap
₹14,808 crore
P/E
87.3
P/B
16.97
ROE
22.8%
Dividend yield
0.61%

AstraZeneca Pharma India ranks 35th by market capitalisation among 71 Pharmaceuticals companies tracked by ATS. Its largest peers are Sun Pharmaceutical Industries, Divi's Laboratories and Torrent Pharmaceuticals. Its P/E of 87.3 compares with a peer median of 33.6.

AstraZeneca Pharma India vs Pharmaceuticals peers

Sorted by market capitalisation.

AstraZeneca Pharma India and peers compared on size, valuation and returns
CompanyClose (₹)1DMarket cap (₹ cr)P/EP/BROE1Y return
Sun Pharmaceutical Industries1,773.60-1.69%4,25,54635.25.0914.7%+12.5%
Divi's Laboratories9,586.00+0.38%2,54,47887.015.1816.2%+12.5%
Torrent Pharmaceuticals4,693.90-1.64%1,58,86372.818.9427.1%+12.5%
Zydus Lifesciences1,151.30-0.71%1,15,84825.74.2719.7%+12.5%
Laurus Labs2,052.90+0.14%1,10,827101.420.9118.2%+12.5%
Cipla1,333.00-0.54%1,07,67732.03.1311.8%+12.5%
Mankind Pharma2,496.00-0.16%1,03,04250.46.3212.5%+12.5%
Dr. Reddy's Laboratories1,194.90-1.08%99,53330.12.6012.1%+12.5%
Aurobindo Pharma1,677.90-0.88%97,45326.32.579.9%+12.5%
Lupin2,006.70-1.11%91,74216.64.0926.9%+12.5%
AstraZeneca Pharma India5,923.00-0.96%14,80887.316.9722.8%+22.0%

Source: NSE end-of-day prices; ratios from company filings. Data as of 7 October 2026. How this data is compiled.

AstraZeneca Pharma India peer comparison — frequently asked questions

Who are AstraZeneca Pharma India's competitors?

AstraZeneca Pharma India's listed peers in Pharmaceuticals include Sun Pharmaceutical Industries, Divi's Laboratories, Torrent Pharmaceuticals, Zydus Lifesciences, Laurus Labs and Cipla, ranked here by market capitalisation.

How does AstraZeneca Pharma India's P/E compare with its peers?

AstraZeneca Pharma India trades at a P/E of 87.3, against a median of 33.6 across the 10 Pharmaceuticals peers shown.

Which is the largest company among AstraZeneca Pharma India's peers?

By market capitalisation, the largest company in the group is Sun Pharmaceutical Industries at ₹4.26 lakh crore, against ₹14,808 crore for AstraZeneca Pharma India.

Same Data For Peers

Trade AstraZeneca Pharma India With ATS

Track ASTRAZEN live and place orders from the Pocket app or the Pocket Web terminal with an ATS trading and demat account.

Figures are for information only and are not investment advice or a recommendation to buy, sell or hold any security. Investments in securities are subject to market risks; read all related documents carefully before investing.